TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
2.170
-0.020 (-0.91%)
At close: Feb 21, 2025, 4:00 PM
2.180
+0.010 (0.46%)
After-hours: Feb 21, 2025, 7:47 PM EST
TCRX's stock price has decreased by -70.72% in the past year and price targets may not have had time to catch up.
TScan Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$11.40
Upside
+425.35%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +591.24% | Dec 11, 2024 |
Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +406.91% | Dec 11, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +591.24% | Nov 15, 2024 |
Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +406.91% | Nov 12, 2024 |
Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +406.91% | Nov 6, 2024 |
Wedbush | Wedbush | Buy Reiterates $10 | Buy | Reiterates | $10 | +360.83% | Aug 13, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +591.24% | Aug 13, 2024 |
Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +406.91% | Aug 12, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +591.24% | Jun 4, 2024 |
BTIG | BTIG | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +453.00% | May 16, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +591.24% | May 14, 2024 |
Needham | Needham | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +406.91% | May 13, 2024 |
Wedbush | Wedbush | Buy Reiterates $10 | Buy | Reiterates | $10 | +360.83% | Apr 23, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +591.24% | Mar 7, 2024 |
Barclays | Barclays | Buy Maintains $7 → $9 | Buy | Maintains | $7 → $9 | +314.75% | Mar 7, 2024 |
Wedbush | Wedbush | Buy Reiterates $9 | Buy | Reiterates | $9 | +314.75% | Feb 1, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.